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Heparan sulfates (HSs) are complex and highly active molecules that are
required for synaptogenesis and long-term potentiation. A deficit in HSs
leads to autistic phenotype in mice. Here, we investigated the long-term
effect of heparinase I, which digests highly sulfated HSs, on the spontaneous
bioelectrical activity of neuronal networks in developing primary hippocam-
pal cultures. We found that chronic heparinase treatment led to a significant
reduction of the mean firing rate of neurons, particularly during the period
of maximal neuronal activity. Furthermore, firing pattern in heparinase-
treated cultures often appeared as epileptiform bursts, with long periods of
inactivity between them. These changes in network activitywere accompanied
by an increase in the frequency and amplitude of miniature postsynaptic excit-
atory currents, which could be described by a linear up-scaling of current
amplitudes. Biochemically, we observed an upregulation in the expression
of the glutamate receptor subunit GluA1, but not GluA2, and a strong increase
in autophosphorylation of a and b Ca2þ/calmodulin-dependent protein
kinase II (CaMKII), without changes in the levels of kinase expression.
These data suggest that a deficit in HSs triggers homeostatic synaptic plasticity
and drastically affects functional maturation of neural network.1. Introduction
Heparan sulfates (HSs) are unbranched sulfated polysaccharides composed of glu-
curonic acid and N-acetylglucosamine. During their biosynthesis in the Golgi
apparatus, these glycosaminoglycans are highly modified by sulfation and C5
epimerization of glucuronic acid, leading to heterogeneity in HS structures.
Specific combinations of glycosaminoglycan-modifying enzymes generate specific
functional microdomains in the glycosaminoglycan chains, which bind selecti-
vely with various growth factors, morphogens, axon guidance molecules and
extracellular matrix (ECM) proteins [1].
HSs are covalently attached to proteoglycans (HSPGs), amongwhich are ECM
molecules perlecan, agrin, collagen XVIII and cell surface molecules such as gly-
picans and syndecans. The latter can be shed and incorporated into the ECM
through interactions with fibronectin, laminins, endostatin, thrombospondins
and collagens [2]. During neural development, HSPGs modulate signalling
through key regulatory secreted proteins such as bone morphogenetic protein,
fibroblast growth factor (FGF) and sonic hedgehog protein by acting on their
receptor activation and signal spreading [3]. Interaction between HSPGs and
the polysialylated form of the neural cell adhesion molecule (NCAM) was
originally found to stimulate NCAM-dependent synaptogenesis in an FGF and
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Figure 1. Heparinase treatment induces epileptiform spiking activity. Raster plots of spontaneous spiking activity in primary hippocampal cultures at DIV 20, treated
with PBS (a), heat-inactivated heparinase (b) or active heparinase (c). Scale bar is 20 s, valid for (a– c). Each stick of represented raster plots shows a spike recorded
from one of nine electrodes of the microelectrode array. A high synchronization of activity recorded in most electrodes is obvious. The duration of demonstrated raster
plots is 100 s. Neurons treated by heparinase show abnormally long (up to 70 s) epileptiform bursts of bursts, whereas cultures from control groups show shorter
regular bursting episodes. A difference in bursting pattern in (a) and (b) reflects physiological variability, common for both control conditions. Developmental
changes of mean firing rate (d ) and mean frequency of bursts of bursts (e) in treated cultures. Both parameters of neuronal network activity reach the maximum
at DIV 20. Increase of epileptiform activity in heparinase-treated cultures parallels the fall in overall mean firing rate relative to control groups. Data are presented as
the mean+ s.e.m., n ¼ 15–17. Statistical analysis was performed using a two-way analysis of variance (ANOVA), SNK was used as a post hoc ANOVA test. The
difference between groups was considered significant if *p, 0.05. (Online version in colour.)
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A more recent study identified glypicans 4 and 6 as astrocyte-
secreted signals sufficient to induce functional excitatory
synapses by increasing the surface level and clustering, but not
overall cellular protein level, of the GluA1 subunit of the
AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic
acid) glutamate receptors (AMPARs) [5]. Acute enzymatic treat-
ment of hippocampal slices with heparinases results in a
reduction of long-term potentiation in CA3–CA1 synapses
and prevents the increase in the density of perforated synapses
normally associated with induction of long-term potentiation
[4,6]. Conditional inactivation of Ext1, the gene encoding an
enzyme essential for HS synthesis, recapitulates a number of
autistic symptoms, including impairments in social interaction,
expressionof stereotyped, repetitivebehaviourand impairments
in ultrasonic vocalization [7].
Here, we aimed at investigating the effects of HS removal at
the network level and at dissecting the underlying synaptic
and molecular mechanisms. Unlike previous studies of synaptic
plasticity [4,6], which used a mixture of heparinases, we treated
cultured dissociated hippocampal neurons with heparinase I,
which preferentially cleaves highly sulfated heparan sulfates
(HSHSs), thus allowing us to assess the function of specific HS
moieties. Our results demonstrate that a deficit of this type of
HSs leads to appearance of long-lasting neuronal discharges sep-
aratedby long intervals of neuronal silence, so themeanneuronal
firing rate is reduced. At the synaptic level, these changes wereaccompanied by homeostatic plasticity in the form of synaptic
up-scaling [8], i.e. excitatory synapses on pyramidal cells were
equally ‘scaled up’ due to the increase in postsynaptic AMPA
receptor expression, as detected by analysis of miniature
excitatory postsynaptic current (mEPSC) amplitude distribution.2. Results
(a) Abnormal network activity after heparinase
treatment
Chronic treatment of hippocampal cultures with heparinase I
(0.5 U ml21) was performed starting from 11th day in vitro
(DIV) to avoid potential effects of enzyme on early neuronal
differentiation. The treatment did not affect cellular composition
of cultures containingbothMAP2-immunopositive neurons and
GFAP-immunopositive astrocytes (electronic supplementary
material, figure S1). In microelectrode recordings, heparinase
treatment resulted in the appearance of long-lasting epileptiform
discharges (figure 1c). These spike bursts lasted up to 70 s at DIV
17–20 and were separated by long periods (minutes) of silence,
unlike in control cultures in which activity was more regular
(figure 1a,b). As a result, the mean firing frequency of neurons
was reduced on DIV 16–20 and there was no prominent peak
in mean firing rate on DIV 20, as observed in the control
groups (figure 1d). Detailed analysis of bursts revealed that the
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the active heparinase was much higher from DIV 16 compared
with the groups treated with PBS or heat-inactivated heparinase
(figure 1e). Heparinase-induced bursting activity peaked at DIV
20 (figure 1e), which corresponded to the day with maximum
frequency of spike generation in the control groups.
(b) Up-scaling of excitatory synaptic currents by
heparinase treatment
Wenext consideredwhether the changes in network excitability
induced by enzymatic removal of HSHSswere related to altera-
tions of the excitation/inhibition ratio. To this aim, we
performed concomitant recordings of miniature excitatory and
inhibitory postsynaptic currents (mEPSCs andmIPSCs, respect-
ively) after heparinase treatment performed as described in the
previous section. Removal of HSHSs selectively increased excit-
atory synaptic input on DIV 18, while leaving unaffected
spontaneous inhibitory synaptic transmission (figure 2a,b),
with a consequent increase in excitation/inhibition ratio.
Specifically, mEPSC amplitude and frequencywere augmented
by 64 and 160%, respectively; no changes in mEPSC waveform
were observed (electronic supplementary material, figure S2).
These findings suggest that HSPGs play a major role in shap-
ing excitatory synaptic transmission during maturation of
neural networks.
Considering that ECM regulates several aspects of homeo-
static synaptic plasticity (HSP) [9–11], we next asked whether
the regulation of excitatory synaptic transmission by HSPGs
shared some mechanisms with HSP. Indeed, we noted that
heparinase-dependent up-scaling of mEPSC amplitudes fol-
lowed a multiplicative rule (figure 2c), as seen for synaptic
scaling in response to activity deprivation in primary neuronal
cultures [8,12].
(c) Biochemical modifications after heparinase
treatment
The observed increase in mEPSC amplitude and frequency
couldbe the consequence of elevated expressionofAMPARsub-
units. Therefore, we next investigated whether the levels of
GluA1 and GluA2, the two major AMPAR subunits at central
synapses,were alteredby chronic heparinase treatment.Western
blot analysis of GluA1 and GluA2 expression was performed
on primary hippocampal neurons on DIV 19 after heparinase
treatment starting fromDIV 11, as in electrophysiological exper-
iments (figure 3a).Heparinase treatment resulted in a statistically
significant 1.32+0.03-fold increase in the protein levels for
GluA1 relative to untreated controls (n ¼ 5, p, 0.001), but
not for GluA2 (1.15+0.07-fold, n ¼ 3, p. 0.1; figure 3c). This
upregulation of GluA1 expression was detected already on
DIV 14 and thus preceded appearance of epileptiform activity
(electronic supplementary material, figure S3).
A previous study has shown that HSP-associated upregu-
lation of GluA1 protein levels could be triggered by an
increase in b Ca2þ/calmodulin-dependent protein kinase II
(bCaMKII) expression [13]. Because regulation of kinase
activity of both a and b CaMKII isoforms strongly depends
on autophosphorylation at Thr286 and Thr287, respectively
(reviewed in [14]), we decided to assess whether heparinase
treatment affects protein expression or autophosphorylation
of these two major forebrain CaMKII isoforms in primary
hippocampal neurons (figure 3b). Indeed, we found thatheparinase upregulated autophosphorylation of both a and
b CaMKII by 3.06+0.47-fold (n ¼ 3, p, 0.05) and 2.26+
0.26-fold (n ¼ 4, p, 0.05), respectively, without altering
total protein levels (0.97+ 0.05-fold, n ¼ 4, p. 0.1 and
1.06+ 0.06-fold, n ¼ 4, p. 0.1, respectively; figure 3c).
Because CaMKII phosphorylates GluA1 on Ser831 and
this site is critical for CaMKII-induced potentiation of
GluA1 currents [15], we verified whether phosphorylation
of GluA1 at this site is increased after heparinase treatment.
Using phospho-specific antibodies, we observed a tendency
in increase of P-Ser831 GluA1/total GluA1 ratio (1.21+0.14,
p ¼ 0.16, n ¼ 4; electronic supplementary material, figure
S4A, B) and a significant increase in the level of P-Ser831
GluA1/tubulin ratio (1.60+0.11, p, 0.05, n ¼ 4; electronic
supplementary material, figure S4A, C) in heparinase-treated
cultured hippocampal neurons, as compared to control.
Thus, we show that heparinase treatment elevates expression
of both the total and Ser831-phosphorylated GluA1.
Taken together, these data suggest that HSHS removal
upregulates GluA1 expression, possibly as a consequence of
the increase in CaMKII autophosphorylation.3. Discussion
At the network level, the heparinase treatment led to a
reduction in mean firing rate, with the appearance of highly
synchronous epileptiform discharges separated by long
periods of inactivity. Generation of epileptiform activity in
heparinase-treated cultures is noteworthy in the light of mul-
tiple autistic features of HS-deficient Ext1 knockout mice [7]
and frequent appearance of seizures as comorbidity in
autism spectrum disorders [16].
At the synaptic level, we revealed that heparinase treatment
elevated glutamatergic transmission in hippocampal neurons,
while no changes in efficacy of inhibitory transmission were
detected. We speculate that the resulting shift in excitation/
inhibition ratio may be the cause of epileptiform activity in
heparinase-treated cultures. Linear up-scaling of mEPSC ampli-
tudes was accompanied by upregulation of GluA1 expression
and upregulation of CaMKII signalling, as reported in previous
studies on HSP [13,17], thus suggesting a mechanistic link
between degradation of HSs and induction of HSP. Considering
the autistic phenotype ofExt1mice deficient inHS, our data sup-
port an emerging link between HSP and autism spectrum
disorders [18]. Interestingly, in Ext1-deficient mice, a reduction
rather than elevation of excitatory transmission was observed
in the amygdala [7]. This is, however, not surprising because
(i) HSPGs are required for synaptogenesis [4,5] and (ii) in the
nervous tissue/organotypic situation the pattern of synaptic
changes underlying HSP is expected to be complex: synaptic
upscaling may be induced in a subset of synapses while others
can be downscaled [19]. From the present and previous [19]
studies, it is plausible to reveal upscaling of mEPSCs in the
CA1 and dentate gyrus principal cells after enzymatic removal
of hippocampal HSHSs in vivo as well as in Ext1-deficient mice.
A parallel study published in this issue [20] demonstrates
that induction of homeostatic plasticity in neuronal cell cultures
by prolonged suppression of neuronal firing is accompanied by
brevican proteolytic processing by ADAMTS4 at inhibitory as
well as excitatory synapses. The authors suggested that such
‘ECM remodelling in conditions of homeostatic plasticity may
liberate synapses to allow for a higher degree of structural
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Figure 2. Chronic heparinase treatment increases mEPSC amplitude and frequency. (a) Simultaneous recordings of mEPSCs and mIPSCs from representative hip-
pocampal neurons of control (left) and heparinase-treated cultures (right). Top, under basal conditions, mEPSCs and mIPSCs are detected as downward and upward
going events, respectively. Middle, application of the AMPAR antagonist NBQX (1 mM) isolates mIPSCs. Bottom, wash-out of NBQX and application of the GABAA
receptor antagonist bicuculline (10 mM) isolates mEPSCs (bottom). (b) Quantification of experiments as in (a) for mEPSC/mIPSC amplitude (left) and mEPSC/mIPSC
frequency (right). Open symbols are averages for individual cells; filled symbols are average cell populations. Heparinase treatment increases mEPSC amplitude and
frequency (**p ¼ 0.01; *p ¼ 0.03; unpaired two-tailed Student’s t-test, n ¼ 8 cells). (c) Left, cumulative distributions of mEPSC amplitude (first 100 events per
cell) in control (black line) and heparinase-treated cultures (green line). The distribution of the scaled control data (grey line) overlapped with the distribution of
heparinase-treated mEPSCs ( p ¼ 0.536 between heparinase and scaled control, p, 0.0009 between heparinase and control; Kolmogorov–Smirnov test),
suggesting a global up-scaling of mEPSCs upon heparinase treatment. Right, mEPSCs (first 100 events per cell) were ranked according to their amplitudes
and plotted against the ranked control distribution (open green circles: heparinase versus control; open black circles: control versus control). The black line represents
the best linear fit ( f (x) ¼ b  x þ a, with b ¼ 1.7254+ 0.00439 and a ¼21.2444+ 0.0511) used to scale the control cumulative distribution in the left
panel. (Online version in colour.)
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vides a complementary view, highlighting that a deficit in
glycans associated with ECM and membrane proteins may
play a causal role in induction of HSP.
HSPcanbe induced in vitroby inhibitionof all spiking activity
with tetrodotoxin, or by inhibition of AMPARswithNBQX or bythe inhibitor of L-type voltage-dependent Ca2þ channels
(L-VDCCs) nifedipine [8,17], suggesting that the reduction in
tonic Ca2þ influx mediated by these channels might be the key
event in this form of plasticity [17]. Interestingly, heparin binds
L-VDCC [21]; moreover, another polyanionic glycan, hyaluronic
acid, supports activityofL-VDCCs [22] and its enzymatic removal
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Figure 3. Heparinase upregulates GluA1 expression and CaMKII activity. Mouse hippocampal neurons were treated with vehicle or heparinase (H1) on DIV 11, 14 and 17.
On DIV 19 cells were lysed and 30 mg of extracts were subjected to immunoblotting (IB). (a) Membranes were probed with anti-GluA1 or anti-GluA2 and anti-tubulin
antibodies, to standardize the level of GluA subunit expression. (b) To assess autophosphorylation level of CaMKII a and b isoforms, membranes were first incubated with
anti-phospho-Thr286 CaMKII antibody and after stripping with an anti-CaMKII antibody (to estimate the total CaMKII level). The lower part of the membrane was probed
with anti-GAPDH to standardize the level of protein expression. (c) Bar graphs representing statistical evaluation of experiments as in (a) and (b). Data are shown as
mean þ s.e.m. There is a statistically significant increase in GluA1 expression level (**p, 0.001; n ¼ 5) and in a (*p, 0.05; n ¼ 3) and in b (*p, 0.05; n ¼ 4)
CaMKII autophosphorylation upon heparinase treatment (the values are normalized relative to the control for each Western blot; Paired t-test or Signed Rank Test was used
for statistical evaluation). (Online version in colour.)
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reported in this study [23]. Thus, modulation of L-VDCC activity
can be one of the mechanisms by which a deficit of HSs induces
HSP. Another option would be HS-mediated modulation of b3
integrins, which are other key players in HSP [12]. This option is
also plausible because HSs bind to a5b1 and avb3 integrins
and integrin ligands may have the same binding site to interact
with either integrins or HSs [24], and hence removal of HSs
may shift interaction of such ligands towards integrins. Further
experiments are warranted to verify these possible mechanisms
and to investigate seizure generation/up-scaling of mEPSCs
after in vivo application of heparinase I or in Ext1-deficient mice.4. Material and methods
(a) Reagents
The following primary antibodies were used in the study: rabbit
polyclonal anti-GluA1 and -GluA2 (AGC-004 and AGC-005,respectively; Alomone Labs), rabbit polyclonal anti-GluA1 phos-
pho-Ser831 (AB5847, Millipore), rabbit polyclonal anti-CaMKII
(RU16, previously described to recognize both a and b isoforms
[25]), rabbit polyclonal anti-phospho-Thr286 CaMKII (p1005–286,
PhosphoSolutions), mouse monoclonal anti-b-tubulin (T5201;
Sigma), mouse monoclonal anti-glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (MAB374, clone 6C5; Millipore), mouse
anti-GFAP (Sigma, G3893) and rabbit anti-MAP2 (Synaptic
Systems, 188002). The following secondary antibodies were used:
horseradish peroxidase (HRP)-conjugated goat anti-mouse
(PR31430) and goat anti-rabbit antibodies (PR31460) from Termo
Scientific, highly cross-adsorbed Alexa Fluor 488 goat anti-mouse
IgG (A11029) and Alexa Fluor 568 goat anti-mouse igG (A111036)
from Invitrogen.
ECL prime Western blotting detection reagent (RPN2232)
was from GE Healthcare. Page ruler prestained protein ladder
plus (PR26620) and non-fat dried milk powder (EMR180001)
Westran CS and 0.45 mm polyvinylidene fluoride (PVDF) blot-
ting membrane (10485289) were purchased from Euroclone.
Phosphatase inhibitor cocktail 2 for tyrosine protein phospha-
tases, acid and alkaline (P5726) and phosphatase inhibitor
rstb.royalsocietypublishing.org
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zymes of alkaline phosphatase (P0044), aprotinin from bovine
lung (A1153), pefabloc (76307) and leupeptin were from Sigma,
BCA Assay Kit (PR23225) was from Termo Scientific.
Heparinase I from Flavobacterium heparinum (EC 4.2.2.7,
Sigma-H2519) was dissolved in phosphate-buffered saline
(PBS) to 200 (100 Uml–1) stock and aliquots were kept at
2808C before use.
(b) Culturing and treatment of neural cells
on microelectrode arrays
Hippocampal cells were dissociated from embryonic mice
(on embryonic day 18) and plated with a high initial density of
approximately 3000 cells mm22 on 6-well microelectrode arrays
(MEAs;Multi Channel SystemsMCSGmbH,Germany) pre-treated
with polyethyleneimine (Sigma P3143) and laminin (Sigma L2020).
S57CL6Jmicewere killed by cervical vertebra dislocation. Embryos
were removed and decapitated. The entire hippocampi were
dissected under sterile conditions. Hippocampi were cut in Ca2þ-
and Mg2þ- free PBS (PBS-minus). After enzymatic digestion for
20 min by 0.25% trypsin-EDTA (Invitrogen 25200–056) at 378C,
cells were separated by trituration (20 passes) in PBS using a 1 ml
pipette tip. After being passed, the solution was centrifuged at
1500g for 2 min, and the cell pellet was immediately re-suspended
in Neurobasal medium (Invitrogen 21103-049) with 2% B27 (Invi-
trogen 17504-044), 0.5 mM L-glutamine (Invitrogen 25030-024),
5% fetal calf serum (PanEco L055) and 0.05% gentamycin (Sigma
G1272) (NBM1). The dissociated cells were plated in a 20 ml droplet
covering the centre of the culture dish on a 1 mm2 electrode region
of each part of a 6-wellMEA, forming a densemonolayer [26]. After
2 h, the dishes were filled with 0.5 ml of NBM1. After 3 days, one
half of the plating medium was replaced by a medium containing
Neurobasal medium with 2% B27, 1 mM L-glutamine and 0.05%
gentamycin (NBM2). Glial growth was not suppressed. One half
of the medium was changed every 3 days. The cells were cultured
under constant conditions of 378C, 5%CO2 and 95%air at saturating
humidity in a cell culture incubator (MCO-18AIC, Sanyo).
One group of cultures received heparinase I treatment
(0.5 U ml21), the second group received the same volume of
PBS (vehicle control group) and the third group was treated
with heat-inactivated heparinase I (1008C for 30 min). The hepar-
inase was added to the cell cultures starting from 11th DIV every
third day during the changes of culture medium. This heparinase
I concentration used was reported to provide the effect close to
maximal [27].
(c) Immunoblot analysis
To access the expression level of endogenous proteins and the
level of their phosphorylation, 30 mg of extracts from hippo-
campal cells (250 000–300 000 plated cells per well, treated in
the same way as for microelectrode array recordings) were resus-
pended in reducing electrophoresis sample buffer 2 (SB2: 4%
SDS, 20% glycerol, 120 mM TRIS, 0.01% bromophenol blue, pH
7.8, 0.2 M DTT, 4% b-mercaptoethanol). Protein extracts were
separated by SDS-PAGE on 7 and 9% acrylamide gels, trans-
ferred to the PVDF membranes with 0.45 mm pore size and
after having been blocked for 40–90 min at room tempera-
ture with 5% milk in TBS-T buffer probed with appropriate
primary antibody at 48C overnight and subsequently with
HRP-goat anti-mouse or goat anti-rabbit secondary antibodies
for 1–2 h at room temperature. Proteins were captured by chemi-
luminescent detection using ImageQuant LAS 4000 (GE
Healthcare, 28-9558-10). Densitometric analysis of the digital
images was performed using IMAGEJ software. To assess the
autophosphorylation level of a and b CaMKII, cell membranes
were first incubated with anti-phospho-Thr286 CaMKII andafter being stripped were reprobed with anti-CaMKII to analyse
the total level of protein. The ratios of autophosphorylation
signal to total amount of CaMKII protein were calculated. To
estimate expression level of GluA1, GluA2, and a and b isoforms
of CaMKII, the amount of protein present in each sample was
standardized to the level of tubulin or GAPDH. To evaluate
GluA1 phosphorylation on Ser831, the ratios between phospho-
Ser831 signal to (i) total amount of GluA1 protein or
(ii) tubulin expression were calculated.
For statistical evaluation and the graphical representation of
the data, the SIGMAPLOT v. 12.5 software was used. The average
+s.e.m. (standard error) was calculated from three or more
experiments for the experimental (heparinase-treated) group, nor-
malized to the control (untreated) group. Statistical evaluationwas
carried out by paired t-test or Signed Rank Test.
(d) Patch clamp recordings
Either heparinase I (0.5 U ml21) or vehicle was applied to mouse
primary hippocampal cultures every third day starting at DIV 11.
Whole-cell patch clamp recordings were performed at room
temperature from hippocampal pyramidal neurons at DIV 18.
Cultures were continuously perfused with an aCSF containing:
130 mM NaCl, 2.5 mM KCl, 0.5 mM CaCl2, 10 mM MgCl2,
10 mM D-glucose and 10 mM HEPES-NaOH (pH 7.38; osmolar-
ity adjusted to 290 mOsm). Blockers of sodium channels (0.5 mM
tetrodotoxin), NMDARs (50 mM D-APV) and L-VDCCs (10 mM
nimodipine) were routinely included in the aCSFs. The intra-
cellular solution contained: 150 mM K-gluconate, 3 mM
KCl, 0.5 mM EGTA, 4 mM Mg-ATP, 0.5 mM Na3-GTP, 20 mM
K2-creatine phosphate and 10 mM HEPES-KOH (pH 7.28; osmo-
larity adjusted to 280 mOsm). In these conditions, the estimated
reversal potential for Cl2 was about 2100 mV. Recordings were
performedwith anEPC10 amplifier (HEKAElektronik, Germany).
Pipette resistance was 2.5–3 MV and there were no significant
differences between compared groups in series resistances and
holding currents.
Miniature excitatory and inhibitory postsynaptic currents
(mEPSCs and mIPSCs) were recorded simultaneously at a hold-
ing potential of 250 mV as inward and outward currents,
respectively. After 2 min, mIPSCs and mEPSCs were sequentially
isolated by applying NBQX (1 mM; 5 min) and subsequently
bicuculline (10 mM; 15 min). Recordings were filtered at 5 kHz
and digitized at 50 kHz. mIPSCs and mEPSCs were scored
over the last minute of NBQX and bicuculline applications,
respectively; detection was performed off-line in ClampFit
(Axon Instruments, USA) using the threshold search algorithm;
detection level was set 2 times higher than the baseline noise
and raw data were visually inspected to eliminate false events;
cells with noisy or unstable baselines were discarded. The
mEPSC and mIPSC weighted decay time constant was calculated
for each single event in IGOR PRO 6.03 (Wavemetrics Inc., USA) as
described elsewhere [12].
Input resistance (Rin), membrane capacitance (Cm) and rest-
ing potential (Vm) were not significantly different in the two
groups (Rin was 403+ 32 MV for control and 287+27 MV for
heparinase, p ¼ 0.10; Cm was 140+12 pF for control and
130+ 9 pF for heparinase, p ¼ 0.74; Vm was 249.5+0.7 mV
for control and 250.3+ 0.8 mV for heparinase, p ¼ 0.48; n ¼ 8
cells each, unpaired two-tailed Student’s t-test).
(e) Microelectrode array recordings
Extracellular potentials were acquired simultaneously through a
MEA120 system (Multi Channel Systems MCS GmbH, Germany),
composed by two amplifiers allowing simultaneous recordings
from two 60-channel planar indium tin-oxide (ITO) electrode
arrays. Each chamber of the 6-well MEAs adopted for this study
was composed of 3  3 (nine) electrodes with a 30 mm diameter
rstb.royalsocietypublishing.org
Ph
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Data were recorded at 10 kHz per channel sampling rate. To ana-
lyse the neural network activity, we recorded spontaneous
bursting activity for 15 min. All of the signal analyses and statistics
were performed using custom made software SPYCODE (Matlab)
[28]. The detection of recorded extracellular spikes was based on
the Precise Timing Spike Detection method [29]. The detection of
bursts was based on the detection of peaks in the inter-spike inter-
val histogram. To detect bursts of bursts in the spiking activity, we
applied the threshold detection algorithm, in which the threshold
was estimated using the inter-burst interval histogram as the value
corresponding to the minimum between the peak for regular
bursts and the next peak [30]. iAll data are presented as the mean+ s.e.m. Statistical analysis
was performed using a two-way analysis of variance (ANOVA)
implemented in the SIGMAPLOT 11.0 program (Systat Software
Inc.). Student–Newman–Keuls (SNK) was used as a post hoc
ANOVA test. The difference between groups was considered
significant if the p-value was less than 0.05.
Acknowledgements. We thank Marina Nanni and Claudia Chiabrera for
excellent technical assistance.
Funding statement. This study was supported by Italian Institute of
Technology (IIT), German Center for Neurodegenerative Diseases
(DZNE), the Russian Federation governmental grant no. 11.G34.31.
0012, Neuron EraNet TargetECM, and by COST Action BM1001
‘Brain Extracellular Matrix in Health and Disease’. l.Trans.R.SoReferences c.B
369:201401341. Maeda N, Ishii M, Nishimura K, Kamimura K. 2011
Functions of chondroitin sulfate and heparan sulfate
in the developing brain. Neurochem. Res. 36,
1228–1240. (doi:10.1007/s11064-010-0324-y)
2. Kirn-Safran C, Farach-Carson MC, Carson DD. 2009
Multifunctionality of extracellular and cell surface
heparan sulfate proteoglycans. Cell Mol. Life Sci. 66,
3421–3434. (doi:10.1007/s00018-009-0096-1)
3. Fico A, Maina F, Dono R. 2011 Fine-tuning of
cell signaling by glypicans. Cell Mol. Life Sci. 68,
923–929. (doi:10.1007/s00018-007-7471-6)
4. Dityatev A, Dityateva G, Sytnyk V, Delling M, Toni N,
Nikonenko I, Muller D, Schachner M. 2004
Polysialylated neural cell adhesion molecule
promotes remodeling and formation of
hippocampal synapses. J. Neurosci. 24, 9372–9382.
(doi:10.1523/JNEUROSCI.1702-04.2004)
5. Allen NJ, Bennett ML, Foo LC, Wang GX,
Chakraborty C, Smith SJ, Barres BA. 2012 Astrocyte
glypicans 4 and 6 promote formation of excitatory
synapses via GluA1 AMPA receptors. Nature 486,
410–414. (doi:10.1038/nature11059)
6. Lauri SE, Kaukinen S, Kinnunen T, Ylinen A, Imai S,
Kaila K, Taira T, Rauvala H. 1999 Regulatory role
and molecular interactions of a cell-surface heparan
sulfate proteoglycan (N-syndecan) in hippocampal
long-term potentiation. J. Neurosci. 19,
1226–1235.
7. Irie F, Badie-Mahdavi H, Yamaguchi Y. 2012
Autism-like socio-communicative deficits and
stereotypies in mice lacking heparan sulfate. Proc.
Natl Acad. Sci. USA 109, 5052–5056. (doi:10.1073/
pnas.1117881109)
8. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC,
Nelson SB. 1998 Activity-dependent scaling of
quantal amplitude in neocortical neurons. Nature
391, 892–896. (doi:10.1038/36103)
9. Dityatev A, Schachner M, Sonderegger P. 2010 The
dual role of the extracellular matrix in synaptic
plasticity and homeostasis. Nat. Rev. Neurosci. 11,
735–746. (doi:10.1038/nrn2898)
10. Gundelfinger ED, Frischknecht R, Choquet D, Heine
M. 2010 Converting juvenile into adult plasticity:
a role for the brain’s extracellular matrix. Eur. J.
Neurosci. 31, 2156–2165. (doi:10.1111/j.1460-
9568.2010.07253.x)11. Thalhammer A, Cingolani LA. 2014 Cell
adhesion and homeostatic synaptic plasticity.
Neuropharmacology 78, 23–30. (doi:10.1016/j.
neuropharm.2013.03.015)
12. Cingolani LA, Goda Y. 2008 Differential involvement of
beta3 integrin in pre- and postsynaptic forms of
adaptation to chronic activity deprivation. Neuron Glia
Biol. 4, 179–187. (doi:10.1017/S1740925X 0999024X)
13. Groth RD, Lindskog M, Thiagarajan TC, Li L, Tsien
RW. 2011 Beta Ca2þ/CaM-dependent kinase type II
triggers upregulation of GluA1 to coordinate
adaptation to synaptic inactivity in hippocampal
neurons. Proc. Natl Acad. Sci. USA 108, 828–833.
(doi:10.1073/pnas.1018022108).
14. Coultrap SJ, Bayer KU. 2012 CaMKII regulation in
information processing and storage. Trends Neurosci.
35, 607–618. (doi:10.1016/j.tins.2012.05.003)
15. Barria A, Derkach V, Soderling T. 1997 Identification
of the Ca2þ/calmodulin-dependent protein kinase II
regulatory phosphorylation site in the alpha-amino-
3-hydroxyl-5-methyl-4-isoxazole-propionate-type
glutamate receptor. J. Biol. Chem. 272, 32 727–
32 730. (doi:10.1074/jbc.272.52.32727)
16. Levisohn PM. 2007 The autism-epilepsy connection.
Epilepsia 48(Suppl. 9), 33–35. (doi:10.1111/j.1528-
1167.2007.01399.x)
17. Thiagarajan TC, Lindskog M, Tsien RW. 2005
Adaptation to synaptic inactivity in hippocampal
neurons. Neuron 47, 725–737. (doi:10.1016/j.
neuron.2005.06.037)
18. Wondolowski J, Dickman D. 2013 Emerging links
between homeostatic synaptic plasticity and
neurological disease. Front Cell Neurosci. 7, 223.
(doi:10.3389/fncel.2013.00223)
19. Kim J, Tsien RW. 2008 Synapse-specific adaptations
to inactivity in hippocampal circuits achieve
homeostatic gain control while dampening network
reverberation. Neuron 58, 925–937. (doi:10.1016/j.
neuron.2008.05.009)
20. Valenzuela JC, Heise C, Franken G, Singh J, Schweitzer
B, Seidenbecher CI, Frischknecht R. 2014 Hyaluronan-
based extracellular matrix under conditions of
homeostatic plasticity. Phil. Trans. R. Soc. B 369,
20130606. (doi:10.1098/rstb.2013.0606)
21. Knaus HG, Scheffauer F, Romanin C, Schindler HG,
Glossmann H. 1990 Heparin binds with high affinityto voltage-dependent L-type Ca2þ channels.
Evidence for an agonistic action. J. Biol. Chem. 265,
11 156–11 166.
22. Kochlamazashvili G et al. 2010 The extracellular
matrix molecule hyaluronic acid regulates
hippocampal synaptic plasticity by modulating
postsynaptic L-type Ca2þ channels. Neuron 67,
116–128. (doi:10.1016/j.neuron.2010.05.030)
23. Vedunova M, Sakharnova T, Mitroshina E, Perminova
M, Pimashkin A, Zakharov Y, Dityatev A, Mukhina I.
2013 Seizure-like activity in hyaluronidase-treated
dissociated hippocampal cultures. Front. Cell
Neurosci. 7, 149. (doi:10.3389/fncel.2013.00149)
24. Faye C, Moreau C, Chautard E, Jetne R, Fukai N,
Ruggiero F, Humphries MJ, Olsen BR, Ricard-Blum S.
2009 Molecular interplay between endostatin,
integrins, and heparan sulfate. J. Biol. Chem. 284,
22 029–22 040. (doi:10.1074/jbc.M109.002840)
25. Menegon A, Verderio C, Leoni C, Benfenati F,
Czernik AJ, Greengard P, Matteoli M, Valtorta F.
2002 Spatial and temporal regulation of Ca2þ/
calmodulin-dependent protein kinase II activity in
developing neurons. J. Neurosci. 22, 7016–7026.
26. Potter SM, DeMarse TB. 2001 A new approach to
neural cell culture for long-term studies. J. Neurosci.
Methods 110, 17–24. (doi:10.1016/S0165-
0270(01)00412-5)
27. Jiang J, Wu X, Tang H, Luo G. 2013 Apolipoprotein
E mediates attachment of clinical hepatitis C virus to
hepatocytes by binding to cell surface heparan
sulfate proteoglycan receptors. PLoS ONE 8, e67982.
(doi:10.1371/journal.pone.0067982)
28. Bologna LL, Pasquale V, Garofalo M, Gandolfo M,
Baljon PL, Maccione A, Martinoia S, Chiappalone M.
2010 Investigating neuronal activity by SPYCODE
multi-channel data analyzer. Neural Netw. 23,
685–697. (doi:10.1016/j.neunet.2010.05.002)
29. Maccione A, Gandolfo M, Massobrio P, Novellino A,
Martinoia S, Chiappalone M. 2009 A novel algorithm
for precise identification of spikes in extracellularly
recorded neuronal signals. J. Neurosci. Methods 177,
241–249. (doi:10.1016/j.jneumeth.2008.09.026)
30. Pasquale V, Martinoia S, Chiappalone M. 2010 A self-
adapting approach for the detection of bursts and
network bursts in neuronal cultures. J. Comput. Neurosci.
29, 213–229. (doi:10.1007/s10827-009-0175-1)
